MEDICAL ADVISORY Released: February 24, 2025, 7:56 PM ESTMedical Advisory: ALTUVIIIO LOT #EY0330 OVERVIEW Sanofi is conducting a voluntary recall of ALTUVIIIO [antihemophilic factor (recombinant), Fc-…
Pfizer, Inc. has announced that they are ceasing global development and commercialization of Beqvez™, the company’s hemophilia B gene therapy product.Beqvez was designed with bioengineered adeno-associated virus (AAVs) vectors to introduce…
Unite for Bleeding Disorders will occur in 35 cities across the country with one mission: to raise funds and awareness for our local chapter and help us increase education, support services, and advocacy efforts in our community.More Info